PACB · Pacific Biosciences of California, Inc.

Summary

Pacific Biosciences of California, Inc. announced Q4 and full year 2025 financial results on February 12, 2026, reporting Q4 revenue of $44.6 million (up 14% YoY) and full year revenue of $160.0 million, with record consumables revenue and strengthened balance sheet from $48.1 million short-read asset sale.

Key takeaways

• Event Type: Earnings Release (Items: 2.02)